Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
- GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma
- Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control
Tweets from GSK
-
GSK @GSK
#DYK there are around 36 million people across the globe living with #severeasthma? We’re committed to help them #LiveEveryBreath and that’s why we’re proud to support the Define Your Asthma campaign. More info: gsk.to/2krJMR4
about 2 hours ago -
GSK @GSK
Vaccine coverage is falling in some regions and diseases like measles are coming back. RT to help raise awareness #vaccinateforlife
about 2 hours ago -
GSK @GSK
#ESPID2018 starts next week and we’ll be there sharing our vaccines science! Follow the conversation @GSK_conferences
about 5 hours ago
